ADC Weekly Digest - 03 to 09 August 2024

ADC Weekly Digest - 03 to 09 August 2024

Clinical
Invenra Highlights Exelixis’ Announcement: Initiation of Phase 1 Clinical Trial Evaluating XB010 in Patients with...
Partnership
Daiichi Sankyo and MSD expand collaboration on ADC development
Clinical
Exelixis drops tissue factor-targeting ADC after deciding it’s no match for Tivdak
Regulatory
Salubris Biotherapeutics Announces European Medicines Agency Approval to Initiate a Phase 1 Clinical Trial of...